EC Number   |
Inhibitors |
Structure |
|---|
    3.2.2.1 | (+-)-1-[(9-deazahypoxanthin-9-yl)methyl]azetidine-2-methanol |
transition state analogue inhibitor, comparison with inhibition of human and Plasmodium falciparum enzyme |
   |
| 3.2.2.1 | (+-)-1-[(9-deazahypoxanthin-9-yl)methyl]azetidine-2-methanol |
transition state analogue inhibitor, comparison with inhibition of bovine and Plasmodium falciparum enzyme |
|
| 3.2.2.1 | (+-)-1-[(9-deazahypoxanthin-9-yl)methyl]azetidine-2-methanol |
transition state analogue inhibitor, comparison with inhibition of human and bovine enzyme |
|
| 3.2.2.1 | (1S)-(1-aminonaphthalen-4-yl)-1,4-dideoxy-1,4-imino-D-ribitol |
- |
|
| 3.2.2.1 | (1S)-1,4-dideoxy-1-(2-guanidinoethyl)-1,4-imino-D-ribitol |
- |
|
| 3.2.2.1 | (1S)-1-(2,3-diamino-5-pyridyl)-1,4-dideoxy-1,4-imino-D-ribitol |
- |
|
| 3.2.2.1 | (1S)-1-(3,4-diaminophenyl)-1,4-dideoxy-1,4-imino-D-ribitol |
- |
|
| 3.2.2.1 | (1S)-1-(4-aminomethyl)phenyl-1,4-dideoxy-1,4-imino-D-ribitol |
- |
|
| 3.2.2.1 | (1S)-1-(4-cyanophenyl)1,4-dideoxy-1,4-imino-D-ribitol |
- |
|
| 3.2.2.1 | (2R,3R,4S)-1-benzyl-2-(hydroxymethyl)pyrrolidine-3,4-diol |
- |
|
